• Price (USD)25.91
  • Today's Change0.07 / 0.27%
  • Shares traded367.60k
  • 1 Year change-26.73%
  • Beta2.7054
Data delayed at least 15 minutes, as of Jan 21 2022 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, Core Laboratories NV (CLB:NYQ) closed at 25.91, 22.91% above the 52 week low of 21.08 set on Dec 17, 2021.
52-week range
21.08Dec 17 202149.87Jun 11 2021
Markit short selling activity
Previous close25.84
Average volume319.75k
Shares outstanding46.29m
Free float46.09m
P/E (TTM)38.12
Market cap1.20bn USD
EPS (TTM)0.6797
Annual div (ADY)0.04
Annual div yield (ADY)0.15%
Div ex-dateNov 05 2021
Div pay-dateNov 29 2021
Data delayed at least 15 minutes, as of Jan 21 2022 21:10 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.